The developing world— which often lacks both a pharmaceutical industry to develop, test, and produce vaccines and the money to purchase them from elsewhere— has been forced to seek supplies from allies or from international groups attempting to obtain vaccines for poor countries.
“China hasn’t been a major vaccine producer globally. It needs to test its COVID-19 vaccines outside its borders because coronavirus cases in China have dwindled and it is harder to find the population diversity required,” read the report.
The publication reported that the state-owned China National Pharmaceutical Group, commonly known as Sinopharm, has teamed up with Karachi University’s International Centre for Chemical and Biological Sciences to hold the trials in Pakistan.
The race for the coronvirus vaccines have heated up in recent weeks with Western countries also pushing their vaccines to the final trial stage. COVID-19 vaccines are currently being developed by the Oxford University and the US-based Moderna Inc.
Though Pakistan lifted the coronavirus lockdown a few days ago, government officials have urged masses to implement COVID-19 SOPs and precautionary measures in order to thwart a second wave of the virus.
During his address at the passing out parade of the Pakistan Air Force at the…
In light of the severe weather conditions in the United Arab Emirates (UAE), Pakistan…
Global investors are eyeing European and emerging market assets to protect themselves from further turbulence…
U.S. central bank officials will conclude their latest two-day policy meeting on Wednesday with a…
Asian stocks sank in holiday-thinned trade Wednesday, tracking a sharp sell-off on Wall Street after…
The Bank of Japan's decision to keep policy unchanged last week gave yen bears plenty…
Leave a Comment